SNDX-50469

N/A

Report date: 2022/05/10 11:40:02
NME

Base Information

Drug NameSNDX-50469
Drug Alias NameSNDX50469VTP50469
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin inhibitors
TargetsMenin
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVitae Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSyndax Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A